Skip to content

Clinical Study on Acupoint Catgut Embedding in Improving Endothelial Dysfunction in Obesity-Associated Erectile Dysfunction

Clinical Study on Improving Endothelial Dysfunction in Obesity-Associated Erectile Dysfunction via Acupoint Catgut Embedding Based on the Principle of "Invigorating Spleen and Tonifying Kidney, Resolving Phlegm and Dispelling Stasis"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002608
Enrollment
Unknown
Registered
2025-12-30
Start date
2026-12-05
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity with Erectile Dysfunction

Interventions

Sponsors

Ethics Committee of the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meet the above diagnostic criteria for the disease, with the diagnosis of ED occurring after obesity;(2) Aged 20-60 years old, with an IIEF-5 score between 5-21 and a disease duration of =3 months;(3) BMI =24 kg/m²;(4) No abnormal blood glucose or lipid levels in the past;(5) No treatment related to this disease received within one month;(6) Having a fixed sexual partner;(7) Willing to cooperate with the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with obvious organic damage;(2) Patients with abnormal blood glucose or lipid levels;(3) Secondary obesity (obesity caused by endocrine disorders, medications, etc.);(4) Patients who are unable to undergo acupoint catgut embedding due to severe needle phobia, coagulation disorders, or other reasons;(5) Patients with hypotension or uncontrolled hypertension;(6) Erectile dysfunction caused by hormonal or neurological factors;(7) Patients allergic to the catgut used in acupoint catgut embedding in this study;(8) Patients with complicated severe cardio-cerebrovascular diseases, other liver, kidney, hematological diseases, or mental illnesses;(9) Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
International Index of Erectile Function-5;

Secondary

MeasureTime frame
Erection Quality Scale;Serum Hormone Levels;NO;ET-1;body weight; Body Mass Index;waist; Waist-Hip Ratio;Waist-Height Ratio;Self-Rating Anxiety;Self-Rating Anxiety Scale;

Countries

China

Contacts

Public Contactxiao caihong

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

775087642@qq.com15685130972

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026